Medullary thyroid cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
:*[[Paraganglioma]] - Negative for keratin, calcitonin and CEA | :*[[Paraganglioma]] - Negative for keratin, calcitonin and CEA | ||
:*[[Carcinoid]] - Negative for calcitonin | :*[[Carcinoid]] - Negative for calcitonin | ||
:*Metastatic Melanoma | :*Metastatic Melanoma<ref>Thyroid Cancer Cancer.gov | ||
(2015). http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq#link/stoc_h2_2- Accessed on October, 29 2015</ref> | |||
==Reference== | ==Reference== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 20:57, 16 November 2015
Medullary thyroid cancer Microchapters |
Differentiating Medullary thyroid cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Medullary thyroid cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Medullary thyroid cancer differential diagnosis |
Risk calculators and risk factors for Medullary thyroid cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Medullary thyroid cancer must be differentiated from anaplastic thyroid carcinoma, papillary thyroid carcinoma, and Hurthle cell carcinoma.
Differentiating Medullary thyroid cancer from other Diseases
- Medullary thyroid cancer must be differentiated from the following:
- Anaplastic thyroid carcinoma.
- Papillary thyroid carcinoma.
- Hurthle cell carcinoma
- Paraganglioma - Negative for keratin, calcitonin and CEA
- Carcinoid - Negative for calcitonin
- Metastatic Melanoma[1]
Reference
- ↑ Thyroid Cancer Cancer.gov (2015). http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq#link/stoc_h2_2- Accessed on October, 29 2015